Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012219
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufacturing and chemical companies. Codexis is headquartered in Redwood City, California, the US.

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Codexis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Codexis Enters into Agreement with Nestle Health Science 11
Codexis Enters into R&D Agreement with Biopharmaceutical Company 13
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 14
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 15
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 16
Licensing Agreements 17
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Equity Offering 22
Codexis Raises USD25.3 Million in Public Offering of Shares 22
Asset Transactions 24
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 24
Acquisition 25
Raizen Energia Acquires 15.7% Stake In Codexis From Equilon Enterprises 25
Codexis Inc – Key Competitors 26
Codexis Inc – Key Employees 27
Codexis Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Nov 09, 2017: Codexis Reports Financial Results for the Third Quarter of 2017 29
Aug 09, 2017: Codexis Reports Financial Results for the Second Quarter of 2017 31
May 09, 2017: Codexis Reports Financial Results for the First Quarter of 2017 33
Mar 09, 2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results 34
Nov 08, 2016: Codexis Reports Financial Results for the Third Quarter of 2016 36
Aug 09, 2016: Codexis Reports Financial Results for the Second Quarter of 2016 38
May 09, 2016: Codexis Reports Financial Results for the First Quarter of 2016 40
Mar 03, 2016: Codexis Reports 2015 Fourth Quarter and Full Year Financial Results 41
Corporate Communications 43
Dec 01, 2016: Codexis names new chairman 43
Mar 03, 2016: Codexis Adds Life Sciences Industry Veteran David V. Smith to Its Board of Directors 44
Legal and Regulatory 45
Aug 08, 2017: Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks 45
Feb 22, 2016: Codexis Files Lawsuit against EnzymeWorks and CEO Junhua “Alex” Tao for Patent Infringement and Misappropriation of Trade Secrets 46
Government and Public Interest 47
Jul 19, 2016: Adding Value in Pharma: Applying Advanced Protein Engineering Technologies to Biotherapeutic Development 47
Product News 49
Jan 06, 2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Codexis Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Codexis Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Codexis Enters into Agreement with Nestle Health Science 11
Codexis Enters into R&D Agreement with Biopharmaceutical Company 13
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 14
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 15
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Codexis Raises USD25.3 Million in Public Offering of Shares 22
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 24
Raizen Energia Acquires 15.7% Stake In Codexis From Equilon Enterprises 25
Codexis Inc, Key Competitors 26
Codexis Inc, Key Employees 27
Codexis Inc, Subsidiaries 28

★海外企業調査レポート[Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Australian Broadcasting Corp:企業の戦略的SWOT分析
    Australian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers active pharmaceutical ingredients and bulk drugs used in anti-neoplastics. It offers products …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Oriental Cuisines Private Limited
    Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report Summary Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fortis Inc (FTS):企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Accredo Health Group Inc:企業の戦略的SWOT分析
    Accredo Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • WidePoint Corp (WYY):企業の財務・戦略的SWOT分析
    Summary WidePoint Corp (WidePoint) operates as a technology company that provides telecommunications lifecycle management, managed mobility, and cybersecurity solutions. The company offers solutions such as telecom expense management, identity management solutions, mobile security solutions, cyberse …
  • Malaysia Airlines Berhad:戦略・SWOT・企業財務分析
    Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report Summary Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Agilent Technologies Inc (A)-医療機器分野:企業M&A・提携分析
    Summary Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The …
  • New York Blood Center:製薬・医療:M&Aディール及び事業提携情報
    Summary New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization's blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical servic …
  • Getinge AB (GETI B)-医療機器分野:企業M&A・提携分析
    Summary Getinge AB (Getinge) is a global medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Broadridge Financial Solutions Inc (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions Inc (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆